FMP

FMP

Enter

LUMO - Lumos Pharma, Inc.

Balance sheet data of Lumos Pharma, Inc.(LUMO), Lumos Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development and comme

photo-url-https://financialmodelingprep.com/image-stock/LUMO.png

Lumos Pharma, Inc.

LUMO

NASDAQ

Lumos Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for rare diseases. Its lead therapeutic candidate LUM-201 is an oral growth hormone secretagogue ibutamoren, which is in Phase 2 clinical trial for the treatment of pediatric growth hormone deficiency and other rare endocrine disorders. The company is headquartered in Austin, Texas.

2.62 USD

0.16 (6.11%)

FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep